multiple myeloma recent progress diagnosis treatment pubmed ncbi abstract multiple myeloma mm intractable hematological disease years recently basic clinical research advanced remarkably therapeutic strategy established introduction high-dose melphalan autologous stem-cell transplantation availability molecular-targeted agents immunomodulatory drugs proteasome inhibitors dramatically changed treatment strategies mm achievement high response rate resulted extension survival research development multimodality therapeutic approaches warranted cure disease 
